Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.03) by 366.67 percent. This is a 107.69 percent increase over losses of $(1.04) per share from the same period last year. The company reported quarterly sales of $75.846 million which beat the analyst consensus estimate of $69.671 million by 8.86 percent. This is a 58.08 percent increase over sales of $47.978 million the same period last year.